Sponsor pipeline

Design Therapeutics, Inc. clinical trial pipeline

Get alerts when Design Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
1
Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07024693 DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy Fuchs Endothelial Corneal Dystrophy Recruiting 2026-09-28
Phase 1/2
NCT06874010 A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia Friedreich Ataxia Recruiting 2025-05-18
Phase 1
NCT06772870 A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants Friedreich Ataxia Not Yet Recruiting 2025-02-21
Get alerts when Design Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free